drugset / Trial / NCT00454350

A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

NCT00454350

Phase 4 Completed 12 enrolled Genzyme, a Sanofi Company
RandomizedCrossoverOpen-labelTreatment

Summary

This study will measure serum levels of the active Vitamin D compound that circulates in hemodialysis subjects treated with either doxercalciferol injection (Hectorol®) or Zemplar® (paricalcitol injection).

Timeline

Start
2007-02
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxercalciferol Small molecule Intravenous
Subject Paricalcitol Other / unclassified Intravenous